IE43136B1 - Isoxazole derivatives, process for their manufacture and pharmaceutical compositions containing these compounds - Google Patents
Isoxazole derivatives, process for their manufacture and pharmaceutical compositions containing these compoundsInfo
- Publication number
- IE43136B1 IE43136B1 IE1202/76A IE120276A IE43136B1 IE 43136 B1 IE43136 B1 IE 43136B1 IE 1202/76 A IE1202/76 A IE 1202/76A IE 120276 A IE120276 A IE 120276A IE 43136 B1 IE43136 B1 IE 43136B1
- Authority
- IE
- Ireland
- Prior art keywords
- group
- carbon atoms
- compound
- formula
- carboxylic acid
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 150000002545 isoxazoles Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- ZYEWRBNSDKQNSJ-UHFFFAOYSA-N 5-methyl-n-phenyl-1,2-oxazole-4-carboxamide Chemical compound O1N=CC(C(=O)NC=2C=CC=CC=2)=C1C ZYEWRBNSDKQNSJ-UHFFFAOYSA-N 0.000 abstract 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
- DYRDKSSFIWVSNM-UHFFFAOYSA-N acetoacetanilide Chemical compound CC(=O)CC(=O)NC1=CC=CC=C1 DYRDKSSFIWVSNM-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- -1 orthoformic acid ester Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2524959A DE2524959C2 (de) | 1975-06-05 | 1975-06-05 | 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE43136L IE43136L (en) | 1976-12-05 |
| IE43136B1 true IE43136B1 (en) | 1980-12-31 |
Family
ID=5948292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1202/76A IE43136B1 (en) | 1975-06-05 | 1976-06-04 | Isoxazole derivatives, process for their manufacture and pharmaceutical compositions containing these compounds |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4087535A (OSRAM) |
| JP (1) | JPS5938230B2 (OSRAM) |
| AT (1) | AT349007B (OSRAM) |
| BE (1) | BE842689A (OSRAM) |
| CA (1) | CA1076584A (OSRAM) |
| CH (1) | CH603608A5 (OSRAM) |
| DK (1) | DK151013C (OSRAM) |
| ES (1) | ES448386A1 (OSRAM) |
| FR (1) | FR2313052A1 (OSRAM) |
| GB (1) | GB1547452A (OSRAM) |
| IE (1) | IE43136B1 (OSRAM) |
| IT (1) | IT1063592B (OSRAM) |
| LU (1) | LU75077A1 (OSRAM) |
| MX (1) | MX3144E (OSRAM) |
| NL (1) | NL178596C (OSRAM) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2654797A1 (de) * | 1976-12-03 | 1978-06-08 | Hoechst Ag | Verfahren zur herstellung von isoxazolderivaten |
| JPS54102196U (OSRAM) * | 1977-12-28 | 1979-07-18 | ||
| DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
| DE3070951D1 (en) * | 1979-06-11 | 1985-09-12 | Ciba Geigy Ag | Alphacarbamoyl-pyrrolpropionitriles, process for their preparation and pharmaceutical preparations containing them |
| DE2940189A1 (de) * | 1979-10-04 | 1981-04-16 | Basf Ag, 6700 Ludwigshafen | Isoxazolylcarbonsaeureanilide, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
| FR2538806B1 (fr) * | 1982-12-30 | 1986-02-21 | Bago Sa Labor | Composes phenyl-3 methyl isoxazole-5 carboxy-4 anilides substitues, actifs therapeutiquement contre l'inflammation et la douleur |
| JPS6398092A (ja) * | 1986-10-14 | 1988-04-28 | 富士電機株式会社 | 金券用カ−ド残金精算装置 |
| US4935434A (en) * | 1988-01-26 | 1990-06-19 | Bristol-Myers Company | Antiarthritic isoxazole-4-carboxamides |
| US5583150A (en) * | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
| DD297328A5 (de) | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen |
| US5001124A (en) * | 1990-02-02 | 1991-03-19 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
| US5108999A (en) * | 1990-02-02 | 1992-04-28 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
| US5494911A (en) * | 1990-05-18 | 1996-02-27 | Hoechst Aktiengesellschaft | Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
| DE4127737A1 (de) * | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
| US6133301A (en) * | 1991-08-22 | 2000-10-17 | Aventis Pharma Deutschland Gmbh | Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
| GB9320299D0 (en) * | 1993-10-01 | 1993-11-17 | Roussel Lab Ltd | Isoxazole derivatives |
| US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
| US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
| US6335356B1 (en) | 1994-01-07 | 2002-01-01 | Sugen, Inc. | Method of treating a patient by parenteral administration of a lipophilic compound |
| US5624946A (en) * | 1994-07-05 | 1997-04-29 | Williams; James | Use of leflunomide to control and reverse chronic allograft rejection |
| US5721277A (en) * | 1995-04-21 | 1998-02-24 | Sugen, Inc. | Compounds and methods for inhibiting hyper-proliferative cell growth |
| US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
| US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
| PT903345E (pt) * | 1997-08-08 | 2001-01-31 | Aventis Pharma Gmbh | Forma cristalina de n-(4-trifluorometilfenil)-5-metil-isoxazolo-4-carboxamida |
| HK1045251A1 (zh) * | 1998-03-11 | 2002-11-22 | Ohio State Research Foundation | Leflunomide产品的抵抗病毒的用途 |
| US7691890B2 (en) | 1998-03-11 | 2010-04-06 | James W. Williams | Anti-viral uses of leflunomide products |
| US20050255071A1 (en) * | 1998-12-10 | 2005-11-17 | Aventis Pharma Deutschland Gmbh | Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors |
| WO2002080897A1 (en) | 2001-04-05 | 2002-10-17 | Aventis Pharmaceuticals Inc. | Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| GB0123571D0 (en) * | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
| DE602004014629D1 (de) * | 2003-09-12 | 2008-08-07 | Rigel Pharmaceuticals Inc | Chinolinverbindungen und deren verwendungen |
| EP1781637A1 (en) * | 2004-06-29 | 2007-05-09 | Rigel Pharmaceuticals, Inc. | 2-substituted quinoline compounds and their uses as inhibitors of the ige receptor signaling cascade |
| US20060024376A1 (en) * | 2004-07-30 | 2006-02-02 | The University Of Chicago | Methods and compositions for reducing toxicity associated with leflunomide treatment |
| JOP20190207A1 (ar) | 2017-03-14 | 2019-09-10 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على بونيسيمود |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK54063C (da) * | 1935-02-22 | 1937-12-27 | Hoffmann La Roche | Fremgangsmaade til Fremstilling af dialkylsubstituerede Amider af Isoksazolkarbonsyrer. |
| DE634286C (de) * | 1935-02-23 | 1936-08-26 | Hoffmann La Roche & Co Akt Ges | Verfahren zur Herstellung dialkylsubstituierter Amide von Isoxazolcarbonsaeuren |
| US2126329A (en) * | 1936-03-20 | 1938-08-09 | Hoffmann La Roche | Amide derivatives of isoxazole carboxylic acids |
| DE673111C (de) * | 1938-01-18 | 1939-03-16 | Hoffmann La Roche & Co Akt Ges | Verfahren zur Darstellung amidartiger Abkoemmlinge von Homologen der Isoxazolcarbonsaeuren |
| DK58903C (da) * | 1940-02-27 | 1941-08-04 | Hoffmann La Roche | Fremgangsmaade til Fremstilling af substituerede Amider af 3,5-Dimetyl-isoksazol-karbonsyre-(4). |
| US2288863A (en) * | 1940-02-27 | 1942-07-07 | Hoffmann La Roche | Process for the manufacture of substituted amides of 3,5-dimethylisoxazole-4-carboxylic acid |
-
1976
- 1976-05-31 ES ES448386A patent/ES448386A1/es not_active Expired
- 1976-05-31 NL NLAANVRAGE7605841,A patent/NL178596C/xx not_active IP Right Cessation
- 1976-06-02 CH CH696276A patent/CH603608A5/xx not_active IP Right Cessation
- 1976-06-03 LU LU75077A patent/LU75077A1/xx unknown
- 1976-06-03 US US05/692,306 patent/US4087535A/en not_active Expired - Lifetime
- 1976-06-03 IT IT23923/76A patent/IT1063592B/it active
- 1976-06-04 GB GB23185/76A patent/GB1547452A/en not_active Expired
- 1976-06-04 MX MX000270U patent/MX3144E/es unknown
- 1976-06-04 IE IE1202/76A patent/IE43136B1/en unknown
- 1976-06-04 JP JP51065476A patent/JPS5938230B2/ja not_active Expired
- 1976-06-04 FR FR7617038A patent/FR2313052A1/fr active Granted
- 1976-06-04 DK DK248376A patent/DK151013C/da not_active IP Right Cessation
- 1976-06-04 CA CA254,134A patent/CA1076584A/en not_active Expired
- 1976-06-04 AT AT413776A patent/AT349007B/de not_active IP Right Cessation
- 1976-06-08 BE BE167707A patent/BE842689A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB1547452A (en) | 1979-06-20 |
| US4087535A (en) | 1978-05-02 |
| DK248376A (da) | 1976-12-06 |
| FR2313052A1 (fr) | 1976-12-31 |
| FR2313052B1 (OSRAM) | 1979-09-28 |
| DK151013B (da) | 1987-10-12 |
| JPS5938230B2 (ja) | 1984-09-14 |
| ATA413776A (de) | 1978-08-15 |
| CA1076584A (en) | 1980-04-29 |
| DK151013C (da) | 1988-03-07 |
| AT349007B (de) | 1979-03-12 |
| IT1063592B (it) | 1985-02-11 |
| CH603608A5 (OSRAM) | 1978-08-31 |
| BE842689A (fr) | 1976-12-08 |
| LU75077A1 (OSRAM) | 1977-03-09 |
| IE43136L (en) | 1976-12-05 |
| ES448386A1 (es) | 1978-04-16 |
| JPS527960A (en) | 1977-01-21 |
| MX3144E (es) | 1980-05-09 |
| NL178596C (nl) | 1986-04-16 |
| NL7605841A (nl) | 1976-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE43136B1 (en) | Isoxazole derivatives, process for their manufacture and pharmaceutical compositions containing these compounds | |
| CA1082202A (en) | Cyano acetic acid anilide derivatives, process for their manufacture and compositions containing these compounds | |
| US5008452A (en) | Aminoethyl oximes | |
| ZA200605460B (en) | The use of N-arylhydrazine derivatives for combating pests in and on animals | |
| CS214826B2 (en) | Method of making the substituted pyranons | |
| US4563448A (en) | Bactericidal agents | |
| DE2524959A1 (de) | Neue isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel | |
| US5449783A (en) | Diphenylthiazole derivative | |
| US4085114A (en) | 1,2-Benzoisoxazole derivatives and the production thereof | |
| US3937841A (en) | Treatment of depression | |
| HU194024B (en) | Bactericide compositions containing quinolone-carboxylic acid derivatives | |
| US4192818A (en) | Compounds having pharmacological properties | |
| Kees et al. | Synthesis and antiallergic activity of a novel series of 5-lipoxygenase inhibitors | |
| JPS61134346A (ja) | ４−オキソカルボン酸誘導体および抗潰瘍剤 | |
| US4895950A (en) | 5-halogeno-6-amino-nicotinic acid halides | |
| US4767767A (en) | 2-pyrrolidinylethyl-2-(7-trifluoromethyl-4-quinolyl-aminobenzoate having analgesic, antipyretic and anti-inflammatory activities | |
| US3301859A (en) | Cinchoninic acids and use in process for quinolinols | |
| GB1595467A (en) | 5-methyliso-oxazole-4-carboxylic acid anilides having pharmaceutical activity | |
| HU206090B (en) | Process for producing new 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| US4235931A (en) | Compounds having pharmacological properties | |
| KR800001453B1 (ko) | 이속사졸 유도체의 제조방법 | |
| US4077968A (en) | Thiazole derivatives | |
| US4658025A (en) | Hydrazine-thiocarboxylic acid O-carbamoylmethyl esters | |
| JPS5927343B2 (ja) | ３−アミノイソオキサゾ−ル類の合成法 | |
| JPS5951542B2 (ja) | ５−フエニル−チアゾリジン−４−オン誘導体の製造方法 |